Evaluation of pluripotent stem cell-derived myeloid line-based chimeric antigen receptor macrophage-like cells identifies limited in vivo persistence
Cytotherapy
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Evaluation of pluripotent stem cell-derived myeloid line-based chimeric antigen receptor macrophage-like cells identifies limited in vivo persistence. // Cytotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926009370?dgcid=rss_sd_all
Evaluation of pluripotent stem cell-derived myeloid line-based chimeric antigen receptor macrophage-like cells identifies limited in vivo persistence. Cytotherapy. https://www.sciencedirect.com/science/article/pii/S1465324926009370?dgcid=rss_sd_all
“Evaluation of pluripotent stem cell-derived myeloid line-based chimeric antigen receptor macrophage-like cells identifies limited in vivo persistence.” Cytotherapy.
@article{article42872,
title = {Evaluation of pluripotent stem cell-derived myeloid line-based chimeric antigen receptor macrophage-like cells identifies limited in vivo persistence},
journal = {Cytotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926009370?dgcid=rss_sd_all}
}